| Table 2: Number of patients presenting clinically active BP, positive anti BP180 autoantibodies, and positive anti BP230 autoantibodies at all different time points. | ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
|
*One case had no signs of clinically active BP, but his anti BP180 autoantibodies had the borderline value of 9.2. | ||||||||||||||||||||||||||||